- Home
- SLVM vs XENE Comparison
SLVM vs XENE Comparison
Compare SLVM & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLVM
- XENE
- Stock Information
- Founded
- SLVM 1898
- XENE 1996
- Country
- SLVM United States
- XENE Canada
- Employees
- SLVM N/A
- XENE N/A
- Industry
- SLVM Paper
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- SLVM Basic Materials
- XENE Health Care
- Exchange
- SLVM Nasdaq
- XENE Nasdaq
- Market Cap
- SLVM 2.5B
- XENE 2.5B
- IPO Year
- SLVM N/A
- XENE 2014
- Fundamental
- Price
- SLVM $52.57
- XENE $35.07
- Analyst Decision
- SLVM Hold
- XENE Strong Buy
- Analyst Count
- SLVM 3
- XENE 9
- Target Price
- SLVM $92.00
- XENE $56.22
- AVG Volume (30 Days)
- SLVM 321.5K
- XENE 872.9K
- Earning Date
- SLVM 05-09-2025
- XENE 05-12-2025
- Dividend Yield
- SLVM 3.42%
- XENE N/A
- EPS Growth
- SLVM 45.68
- XENE N/A
- EPS
- SLVM 6.84
- XENE N/A
- Revenue
- SLVM $3,689,000,000.00
- XENE N/A
- Revenue This Year
- SLVM N/A
- XENE N/A
- Revenue Next Year
- SLVM $0.65
- XENE $1,553.36
- P/E Ratio
- SLVM $7.70
- XENE N/A
- Revenue Growth
- SLVM 0.11
- XENE N/A
- 52 Week Low
- SLVM $54.94
- XENE $26.74
- 52 Week High
- SLVM $98.02
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- SLVM 29.98
- XENE 50.20
- Support Level
- SLVM $58.46
- XENE $34.47
- Resistance Level
- SLVM $60.51
- XENE $36.44
- Average True Range (ATR)
- SLVM 1.83
- XENE 1.44
- MACD
- SLVM -0.14
- XENE -0.19
- Stochastic Oscillator
- SLVM 8.40
- XENE 28.63
About SLVM Sylvamo Corporation
Sylvamo Corp is an uncoated papers company with a broad portfolio of top-tier brands and low-cost, large-scale paper mills, it produces uncoated freesheet (UFS) for paper products such as cut size and offset paper, as well as market pulp. The company offers Copy and Printer papers, Commercial Printing papers, Converting papers and Specialty papers. It operates in three geographical segments: Europe, Latin America, and North America. Key revenue is generated from North America.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.